Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells

Experimental Cell Research

Volumn 314, Issue 10, 2008, Pages 2004-2015

  Larrucea, Susana ^a,c   Butta, Nora ^a,b   Arias Salgado, Elena G ^a,b   Alonso Martin, Sonia ^a   Ayuso, Matilde S ^a,b   Parrilla, Roberto ^a,b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

Author keywords

Actin cytoskeleton; Cell adhesion; Cell cell contact; Glycomutant CHO cells; Migration; Podocalyxin; shRNA; 1 integrins

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; FIBRONECTIN; MONOCLONAL ANTIBODY; PODOCALYXIN; SIALIC ACID; VINCULIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CELL SPREADING; CHO CELL; CYTOSOL; HUMAN; HUMAN CELL; LAMELLIPODIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; VASCULAR ENDOTHELIUM;

EID: 44749091138     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.03.009     Document Type: Article

References (40)

1. Michael A.F., Blau E., and Vernier R.L. Glomerula polyanion: alteration in aminonucleoside nephrosis. Lab. Invest. 23 (1970) 649-657
2. Seiler M.W., Rennke H.G., Venkatachalam M.A., and Cotran R.S. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab. Invest. 36 (1977) 48-61
3. Andrews P.M. Glomerular epithelial alterations resulting from sialic acid surface coat removal. Kidney Int. 15 (1979) 376-385
4. Kerjaschki D., Sharkey D.J., and Farquhar M.G. Identification and characterization of podocalyxin the major sialoprotein of the renal glomerular epithelial cell. J. Cell Biol. 98 (1984) 1591-1596
5. Kerjaschki D., Poczewski H., Dekan G., Horvat R., Balzar E., Kraft N., and Atkins R.C. Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J. Clin. Invest. 78 (1986) 1142-1149
6. Kerjaschki D., Vernillo A.T., and Farquhar M.G. Reduced Sialylation of Podocalyxin-The Major Sialoprotein of the Rat Kidney Glomerulusin Aminonucleoside Nephrosis. Am. J. Pathol. 118 (1985) 343-349
7. Dekan G., Gabel C., and Farquhar M.G. Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5398-5402
8. Kershaw D.B., Thomas P.E., Wharram B.L., Goyal M., Wiggins J.E., Whiteside C.I., and Wiggins R.C. Molecular cloning, expression and characterization of podocalyxin-like protein from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J. Biol. Chem. 270 (1995) 29439-29446
9. Kershaw D.B., Beck S.G., Wharram B.L., Wiggins J.E., Goyal M., Thomas P., and Wiggins E.R.C. Molecular cloning and characterization of human podocalyxin-like protein. J. Biol. Chem. 272 (1997) 15708-15714
10. Charest P.M., and Roth J. Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8509-8512
11. Caulfield J.P., Reid J.J., and Farquhar M.G. Alteration of the glomerular epithelium in acute aminonucleoside nephrosis: evidence for formation of occluding junctions and epithelial cell detachment. Lab. Clin. Invest. 34 (1976) 43-59
12. Doyonnas R., Kershaw D.B., Duhme C., Merkens H., Chelliah S., Graf T., and McNagny K.M. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J. Exp. Med. 194 (2001) 13-27
13. Simons M., Schwarz K., Kriz W., Miettinen A., Reiser J., Mundel P., and Holthofer H. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am. J. Pathol. 159 (2001) 1069-1077
14. Economou C.G., Kitsiou P.V., Tzinia A.K., Panagopoulou E., Marinos E., Kershaw D.B., Kerjaschki D., and Tsilibary E.C. Enhanced podocalyxin expression alters the structure of podocyte basal surface. J. Cell Sci. 117 (2004) 3281-3294
15. Hara T., Nakano Y., Tanaka M., Tamura K., Sekiguchi T., Minehata K., Copeland N.G., Jenkins N.A., Okabe M., Kogo H., Mukouyama Y., and Miyajima A. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region. Immunity 11 (1999) 567-578
16. Kelley T.W., Huntsman D., McNagny K.M., Roskelly C.D., and His E.D. Podocalyxin: a marker of blasts in acute leukaemia. Am. J. Clin. Pathol. 124 (2005) 134-142
17. Schopperle W.M., Kershaw D.B., and DeWolf W.C. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2 is podocalyxin. Biochem. Biophys. Res. Commun. 399 (2003) 285-290
18. Schmelz K., Sattler N., Wagner M., Lubbert M., Dorken B., and Tamm I. Induction of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms. Leukemia 28 (2004) 1-9
19. Somasiri A., Nielsen J.S., Makretsov N., McCoy M.L., Prentice L., Gilks C.B., Chia S.K., Gelmon K.A., Kershaw D.B., Huntsman D.G., McNagny K.M., and Roskelley C.D. Overexpression of anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res. 64 (2004) 5068-5073
20. Casey G., Neville P.J., Liu X., Plummer S.J., Cicek M.S., Krumroy L.M., Curran A.P., McGreevy M.R., Catalona W.J., Klein E.A., and Witte J.S. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum. Mol. Gen. 15 (2006) 735-741
21. Sassetti A.C., Van Zante A., and Rose S.D. Identification of endoglycan, a member of the CD34/Podocalyxin family of sialomucins. J. Biol Chem. 275 (2000) 9001-9010
22. Horvat R., Hovorka A., Dekan G., Poczewski H., and Kerjaschki D. Endothelial cell membranes contain podocalyxin the major sialoprotein of visceral glomerular epithelial cells. J. Cell Biol. 102 (1986) 484-491
23. McNagny K.M., Petterson I., Rossi F., Flamme A., Shevchenko A., Mann M., and Graf T. Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J. Cell Biol. 138 (1997) 1395-1407
24. Miettinen A., Solin M., Reivinen J., Juvonen E., Vaisanen R., and Holthofer H. Podocalyxin in rat platelets and megakaryocytes. Am. J. Pathol. 154 (1999) 813-822
25. Sassetti C., Tangemann K., Singer M.S., Kershaw D.S., and Rosen S.D. Identification of podocalyxin-like protein as a high endothelial venule ligand for l-selectin: parallels to CD34. J. Expt. Med. 187 (1998) 1965-1975
26. Rodriguez R.B., Butta N., Larrucea S., Alonso S., and Parrilla R. Production and characterization of murine monoclonal antibodies against human podocalyxin. Tissue Antigens 68 (2006) 407-417
27. Rieber A.J., Marr H.S., Comer M.B., and Edgell C.J. Extent of differentiated gene expression in the human endothelium-derived EA.hy926 cell line. Thromb. Haemost. 69 (1993) 476-480
28. Larrucea S., Gonzalez-Manchon C., Butta N., Arias-Salgado E.G., Shen L., Ayuso M.S., and Parrilla R. Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. Blood 99 (2002) 2819-2827
29. Takeda T. Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na/H-exchanger regulatory factor 2 and ezrin. Clin. Exp. Nephrol. 7 (2003) 260-269
30. Takeda T., Go W.Y., Orlando R.A., and Farquhar M.G. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol. Biol. Cell. 11 (2000) 3219-3232
31. Schmieder S., Nagai M., Orlando R.A., Takeda T., and Fraguar M.G. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J. Am. Soc. Nephrol. 15 (2004) 2289-2298
32. Andre P., Prasas K.S., Denis C.V., He M., Hynes R.O., Phillips D.R., and Wagner D.D. CD40 stabilized arterial thrombi by a β3 integrin-dependent mechanism. Nat. Med. 8 (2002) 247-252
33. Ikeda K., and Quertermous T. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J. Biol. Chem. 279 (2004) 55315-55323
34. Felschow D.M., McVeigh M.L., Hoehn G.T., Civin C.I., and Fackler M.J. The adapter protein CrkL associates with CD34. Blood 97 (2001) 3768-3775
35. Sabolic I., Herak-Kramberger C.M., Ljubojevic M., Biemesderfer D., and Brown D. NHE3 and NHERF are targeted to the basolateral membrane in proximal tubules of colchicine-treated rats. Kidney Int. 61 (2002) 1351-1364
36. Liedtke C.M., Raghuram V., Yun C.C., and Wang X. Role of a PDZ1 domain of NHERF1 in the binding of airway epithelial RACK1 to NHERF1. Am. J. Physiol. Cell Physiol. 286 (2004) C1037-C1044
37. Takeda T., McQuistan T., Orlando R.A., and Farquhar M.G. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J. Clin. Invest. 108 (2001) 289-301
38. Fukata Y., Amano M., and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22 (2001) 32-39
39. Higgs H.N., and Pollard T.D. Regulation of actin filament network formation through Arp2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70 (2001) 649-676
40. Ridley A.J. Rho GTPases in cell migration. J. Cell Sci. 114 (2001) 2713-2722